These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. ASO Author Reflections: Comparison of Three Lymph Node Staging Systems for Prognostic Evaluation of Resected Gastric Adenocarcinoma. Che K; Wei J Ann Surg Oncol; 2021 Dec; 28(13):8950-8951. PubMed ID: 34156572 [No Abstract] [Full Text] [Related]
63. ASO Author Reflections: Liver Transplantation for Hepatocellular Carcinoma. Wong TCL; Ng KKC Ann Surg Oncol; 2019 May; 26(5):1463-1464. PubMed ID: 30684160 [No Abstract] [Full Text] [Related]
64. ASO Author Reflections: Encapsulated Angio-Invasive Follicular Thyroid Carcinoma: Prognostic Impact of the Extent of Vascular Invasion. Yamazaki H; Katoh R; Sugino K; Matsuzu K; Kitagawa W; Nagahama M; Rino Y; Ito K Ann Surg Oncol; 2022 Feb; ():. PubMed ID: 35138494 [No Abstract] [Full Text] [Related]
65. ASO Author Reflections: Preceding Systemic Chemotherapy Might Provide Better Prognosis for Pancreatic Ductal Adenocarcinoma with Positive Peritoneal Cytology. Ariake K; Mizuma M; Motoi F; Unno M Ann Surg Oncol; 2021 Oct; 28(11):6255-6256. PubMed ID: 33634387 [No Abstract] [Full Text] [Related]
66. ASO Author Reflections: Toward Improved Selection of Patients for Cytoreduction and HIPEC: Identification of Prognostic Factors for Patients with Colorectal Peritoneal Metastases. Sluiter NR; Tuynman JB Ann Surg Oncol; 2018 Dec; 25(Suppl 3):840-841. PubMed ID: 30302638 [No Abstract] [Full Text] [Related]
67. ASO Author Reflections: Preoperative Prediction Score for Early Recurrence of Resected Gallbladder Carcinoma and Consideration of Optimal Treatment Strategies. Shimizu Y; Ashida R; Sugiura T; Okamura Y; Ohgi K; Yamada M; Otsuka S; Aramaki T; Notsu A; Uesaka K Ann Surg Oncol; 2022 Sep; 29(9):5458-5459. PubMed ID: 35650368 [No Abstract] [Full Text] [Related]
68. ASO Author Reflections: Prognostic Significance of Primary Tumor Infiltrating Lymphocytes in the Contemporary Melanoma Era. Straker RJ; Krupp K; Karakousis GC Ann Surg Oncol; 2022 Aug; 29(8):5217-5218. PubMed ID: 35303177 [No Abstract] [Full Text] [Related]
69. ASO Author Reflections: Aberrant Right Hepatic Artery Anatomy, an Independent Prognostic Factor for Hepatic Recurrence of Pancreatic Cancer. Mangieri CW; Clark CJ Ann Surg Oncol; 2022 May; 29(5):3229-3230. PubMed ID: 35147821 [No Abstract] [Full Text] [Related]
70. ASO Author Reflections: Albumin-Bilirubin Grade is an Independent Prognostic Factor Complementary to CA19-9 for Pancreatic Cancer Patients. Imamura T; Okamura Y; Sugiura T; Yamamoto Y; Ito T; Ashida R; Ohgi K; Ohtsuka S; Uesaka K Ann Surg Oncol; 2021 Oct; 28(11):6236-6237. PubMed ID: 33586063 [No Abstract] [Full Text] [Related]
71. ASO Author Reflections: Outcomes for Minimally Invasive Follicular Thyroid Carcinoma in AJCC 8th Edition. Yamazaki H; Sugino K; Katoh R; Matsuzu K; Masuda M; Ito K Ann Surg Oncol; 2021 Jul; 28(7):3584. PubMed ID: 33225393 [No Abstract] [Full Text] [Related]
72. ASO Author Reflections: Prognostic Impact of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer. Shida D Ann Surg Oncol; 2019 Dec; 26(Suppl 3):666-667. PubMed ID: 31359284 [No Abstract] [Full Text] [Related]
73. ASO Author Reflections: Fibrinogen and Albumin Score Validated as a Prognostic Factor to Refine the Treatment Strategy for Esophageal Cancer Patients. Matsuda S; Takeuchi H; Kawakubo H; Takemura R; Maeda Y; Hirata Y; Kaburagi T; Egawa T; Nishi T; Ogura M; Miyasho T; Okamura A; Mayanagi S; Fukuda K; Nakamura R; Irino T; Wada N; Kitagawa Y Ann Surg Oncol; 2020 Dec; 27(Suppl 3):886-887. PubMed ID: 32761333 [No Abstract] [Full Text] [Related]
74. ASO Author Reflections: Pulmonary Metastasectomy in Patients with Lung Metastases from Nasopharyngeal Carcinoma. Zhao ZR; Long H Ann Surg Oncol; 2021 Aug; 28(8):4551-4552. PubMed ID: 33586071 [No Abstract] [Full Text] [Related]
75. ASO Author Reflections: A Novel Three-lncRNA Signature Predictive of Prognoses of HNSCC Patients. Jiang H; Ma B; Xu W; Luo Y; Lu Z; Liao T; Wang X; Wen S; Yang S; Wang Y Ann Surg Oncol; 2021 Jun; 28(6):3407. PubMed ID: 33200328 [No Abstract] [Full Text] [Related]
76. ASO Author Reflections: PTTG1 Protein Expression in Adrenocortical Carcinoma. Romero Arenas MA; Perrier ND Ann Surg Oncol; 2019 Dec; 26(Suppl 3):533-534. PubMed ID: 30519761 [No Abstract] [Full Text] [Related]
77. ASO Author Reflections: Breast Cancer Local Recurrence Versus New Primary-Clinical Predictors and Prognostic Implications. Laird J; Braunstein LZ Ann Surg Oncol; 2018 Dec; 25(Suppl 3):648-649. PubMed ID: 30306376 [No Abstract] [Full Text] [Related]
78. ASO Author Reflections: Evaluation of the 8th AJCC Prognostic Staging System for Breast Cancer in a Latin American Cohort. Cervera-Bonilla S; Guzmán-Abisaab L; Rodríguez-Ossa P Ann Surg Oncol; 2021 Oct; 28(11):6022-6023. PubMed ID: 33837475 [No Abstract] [Full Text] [Related]
79. ASO Author Reflections: Cautious Management of NIFTP. Eskander A Ann Surg Oncol; 2019 Dec; 26(Suppl 3):645-646. PubMed ID: 31222686 [No Abstract] [Full Text] [Related]
80. ASO Author Reflections: Neoadjuvant Therapy for Pancreatic Cancer may Reduce Microscopic Venous Invasion, Which is an Independent Prognostic Factor Associated with Liver Recurrence. Kubo H; Ohgi K; Sugiura T; Ashida R; Yamada M; Otsuka S; Yamazaki K; Todaka A; Sasaki K; Uesaka K Ann Surg Oncol; 2022 Aug; 29(8):5003-5004. PubMed ID: 35381935 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]